Quick summary

Cecropia pachystachya (Ambay) is a Neotropical plant species recognized for its phytochemical diversity, including flavonoids, phenolic acids, and terpenoids. It holds traditional medicinal uses and ecological significance. However, clinical research on this herb remains limited. Preclinical and ethnopharmacological studies have investigated its potential anti-inflammatory, antimicrobial, antioxidant, and cardiovascular-related properties.

What is it

Ambay, scientifically known as Cecropia pachystachya, is a tree native to tropical regions of the Americas. It is part of the Cecropia genus, which is commonly found in Neotropical forests. The plant is valued both ecologically and in traditional medicine systems.

Traditional uses

Traditionally, Cecropia pachystachya has been used in folk medicine for its purported anti-inflammatory and antimicrobial effects, as well as for general health purposes. Its leaves and extracts have been utilized in various preparations by indigenous and local communities.

Active compounds

The plant contains a diverse range of bioactive phytochemicals, notably flavonoids, phenolic acids, and terpenoids. These compounds are thought to contribute to the herb’s reported biological activities.

Potential benefits with evidence levels

  • Anti-inflammatory effects

    Evidence level: Preclinical and traditional use

    Details: Extracts from the Cecropia genus, including C. pachystachya, exhibit anti-inflammatory properties attributed to flavonoid and phenolic acid content.
  • Antimicrobial activity

    Evidence level: Preclinical and in vitro

    Details: Phytochemical studies indicate potential antimicrobial effects, although specific clinical data for C. pachystachya are lacking.
  • Antioxidant effects

    Evidence level: Preclinical and traditional use

    Details: The herb contains antioxidants such as flavonoids and phenolic acids that have been demonstrated in laboratory studies.
  • Potential anti-hypertensive activity

    Evidence level: Preclinical and animal studies

    Details: Systematic reviews of natural products related to C. pachystachya report antihypertensive effects linked with flavonoids and terpenoids, but direct clinical trials on this species are not available.
  • Hypoglycemic effects

    Evidence level: Animal studies

    Details: Animal models such as alloxan-induced diabetic rats showed hypoglycemic effects from C. pachystachya extracts; however, no human trials have been conducted.

Side effects

There are no specific adverse effects documented from clinical trials or human studies involving Cecropia pachystachya. Animal studies suggest the extracts are generally tolerated, but the safety profile in humans remains unclear.

Drug interactions

Currently, no evidence exists from clinical or preclinical studies indicating drug interactions with Cecropia pachystachya.

Who should avoid it

No specific contraindications have been identified in the available research. However, due to lack of safety data, pregnant or breastfeeding individuals should exercise caution and consult healthcare providers before using this herb.

Evidence limitations

  • No randomized controlled trials or human clinical trials evaluating efficacy or safety of C. pachystachya were found.
  • Most available evidence is based on phytochemical analyses, traditional use, animal models, and in vitro studies.
  • Clinical relevance, effective human dosages, and comprehensive safety profiles remain undetermined.
  • Data on potential drug interactions and adverse effects in humans are lacking.

References

Last reviewed

April 2024

Disclaimer: This page is for informational purposes only and does not constitute medical advice. The scientific evidence regarding Cecropia pachystachya is limited and preliminary. Consult a healthcare professional before using this herb, especially if you are pregnant, breastfeeding, have a medical condition, or are taking medications.